SCHEMBL322266

SCHEMBL322266

[CH2]CCCCCC[S+](C)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL788204 1.00
SCHEMBL321306 1.00
SCHEMBL788740 1.00
SCHEMBL5074216 1.00
SCHEMBL321487 1.00
SCHEMBL798364 1.00
SCHEMBL322259 0.97
SCHEMBL185817 0.88
SCHEMBL17675714 0.85
SCHEMBL185215 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240156846-A1 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS NATIONAL INSTITUTES OF HEALTH 2024-05-16 US claimed
CN-113383796-A Plant growth regulator for promoting corn grain filling and application thereof 天津天隆在田农业科技有限公司 2021-09-14 CN claimed
EP-3812464-A1 ELEVATED RESISTANCE TO INSECTS AND PLANT PATHOGENS WITHOUT COMPROMISING SEED PRODUCTION Board of Trustees of Michigan State University (US) 2021-04-28 EP claimed
US-20210115464-A1 ELEVATED RESISTANCE TO INSECTS AND PLANT PATHOGENS WITHOUT COMPROMISING SEED PRODUCTION UNITED STATES DEPARTMENT OF ENERGY 2021-04-22 US claimed
EP-1313377-B1 TREATMENT OF HELICOBACTER WITH ISOTHIOCYANATES FAHEY JED W (US) 2015-01-21 EP claimed
EP-2257630-A2 BIOSYNTHETIC ENGINEERING OF GLUCOSINOLATES University of Copenhagen (DK) 2010-12-08 EP claimed
US-20090326056-A1 NOVEL ACTIVES AGAINST PROSTATE CARCINOMA DSM IP ASSETS B.V. (NL) 2009-12-31 US claimed
WO-2009106985-A2 BIOSYNTHETIC ENGINEERING OF GLUCOSINOLATES UNIVERSITY OF COPENHAGEN (DK) 2009-09-03 WO claimed
EP-1569628-B1 NOVEL USE OF LYCOPENE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ANDROGEN SIGNALLING DSM IP ASSETS BV (NL) 2009-07-22 EP claimed
CN-101442995-A Novel actives against prostate carcinoma DSM IP ASSETS BV (NL) 2009-05-27 CN claimed
EP-2020997-A2 NOVEL ACTIVES AGAINST PROSTATE CARCINOMA DSMIP Assets B.V. (NL) 2009-02-11 EP claimed
WO-2007131767-A2 NOVEL ACTIVES AGAINST PROSTATE CARCINOMA DSM IP ASSETS B.V. (NL) 2007-11-22 WO claimed
US-20060069151-A1 Novel use of lycopene DSM IP ASSETS B.V. (NL) 2006-03-30 US claimed
US-20060020046-A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies DMS IP ASSETS B.V. (NL) 2006-01-26 US claimed
EP-1569628-A1 NOVEL USE OF LYCOPENE DSM IP Assets B.V. (NL) 2005-09-07 EP claimed
EP-1476143-A1 COMPOSITIONS COMPRISING LYCOPENE FOR THE TREATMENT AND PREVENTION OF ANGIOGENESIS ASSOCIATED PATHOLOGIES DSM IP Assets B.V. (NL) 2004-11-17 EP claimed
WO-2004052351-A1 NOVEL USE OF LYCOPENE DSM IP ASSETS B.V. (CH) 2004-06-24 WO claimed
WO-2003068202-A1 COMPOSITIONS COMPRISING LYCOPENE FOR THE TREATMENT AND PREVENTION OF ANGIOGENESIS ASSOCIATED PATHOLOGIES DSM IP ASSETS B.V. (NL) 2003-08-21 WO claimed
WO-2024105148-A1 PLANTS WITH LOW SEED GLUCOSINOLATE CONTENT UNIVERSITY OF COPENHAGEN (DK) 2024-05-23 WO disclosed
WO-2002015722-A2 TREATMENT OF HELICOBACTER WITH ISOTHIOCYANATES FAHEY JED W (US) 2002-02-28 WO disclosed